CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | -100.0% | 78 | -98.9% | 0.00% | – |
Q3 2018 | $3,000 | -96.6% | 7,016 | -96.0% | 0.00% | – |
Q2 2018 | $89,000 | -70.5% | 176,755 | +36.1% | 0.00% | – |
Q1 2018 | $302,000 | +411.9% | 129,854 | +522.4% | 0.00% | – |
Q4 2017 | $59,000 | +353.8% | 20,865 | +350.1% | 0.00% | – |
Q3 2017 | $13,000 | +550.0% | 4,636 | +337.8% | 0.00% | – |
Q2 2017 | $2,000 | -97.1% | 1,059 | -94.3% | 0.00% | – |
Q1 2017 | $68,000 | +112.5% | 18,641 | +103.3% | 0.00% | – |
Q4 2016 | $32,000 | -3.0% | 9,170 | +9.4% | 0.00% | – |
Q3 2016 | $33,000 | -66.7% | 8,384 | -74.6% | 0.00% | – |
Q1 2016 | $99,000 | -96.7% | 33,050 | -83.6% | 0.00% | -100.0% |
Q4 2015 | $3,026,000 | +984.6% | 201,714 | +624.7% | 0.00% | – |
Q3 2015 | $279,000 | +125.0% | 27,835 | +461.9% | 0.00% | – |
Q2 2015 | $124,000 | -83.9% | 4,954 | -82.6% | 0.00% | -100.0% |
Q1 2015 | $769,000 | -78.7% | 28,493 | -85.8% | 0.00% | -66.7% |
Q4 2014 | $3,613,000 | +125.5% | 200,688 | +50.3% | 0.00% | +50.0% |
Q3 2014 | $1,602,000 | -21.8% | 133,486 | +4.2% | 0.00% | 0.0% |
Q2 2014 | $2,049,000 | -17.2% | 128,078 | -12.1% | 0.00% | -33.3% |
Q1 2014 | $2,476,000 | -59.9% | 145,641 | -43.4% | 0.00% | -50.0% |
Q4 2013 | $6,174,000 | +24.9% | 257,187 | +82.1% | 0.01% | 0.0% |
Q3 2013 | $4,944,000 | +2587.0% | 141,263 | +1095.8% | 0.01% | – |
Q2 2013 | $184,000 | – | 11,813 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
Overbrook Management Corp | 48,611 | $22,000 | 0.00% |